Additive [qlco]    
Modification [ftcn]    
HEPATOCELLULAR CARCINOMA [neop]    
HEPATITIS B E ANTIGEN [imft]    
Interaction [ftcn]    
HEPATOCELLULAR CARCINOMA [neop]    
Case-Control Study [resa]    
included [ftcn]    
Sex [orgf]    
matched [resa]    
Pair [qlco]    
Patients [podg]    
Histologically [ftcn]    
Proven [qlco]    
HEPATOCELLULAR CARCINOMA [neop]    
HEALTHY SUBJECTS [popg]    
control [qlco]    
HEPATITIS B E ANTIGEN [imft]    
HEPATITIS B E ANTIGEN [imft]    
Detected [fndg]    
Radioimmunoassay [lbpr]    
Prevalences [qnco]    
HEPATITIS B E ANTIGEN [imft]    
Cases [ftcn]    
Higher [qlco]    
control [qlco]    
1 - 9% [fndg]    
Patients [podg]    
Negative [qlco]    
HEPATITIS B E ANTIGEN [imft]    
HBe Ag [imft]    
Referent group [popg]    
univariate analysis [resa]    
Indicated [fndg]    
Alone [qnco]    
HEPATITIS B E ANTIGEN [imft]    
Risk Factors [qnco]    
HEPATOCELLULAR CARCINOMA [neop]    
Trend [tmco]    
CALCULATION [acty]    
Incremental [qnco]    
Odds Ratio [qnco]    
Indicated [fndg]    
Additive [qlco]    
Interaction [ftcn]    
HEPATITIS B E ANTIGEN [imft]    
Indicated [fndg]    
HEPATOCELLULAR CARCINOMA [neop]    
HEPATITIS B E ANTIGEN [imft]    
Odds Ratio [qnco]    
Odds Ratio [qnco]    
Odds Ratio [qnco]    
HEPATITIS B E ANTIGEN [imft]    
Independent [idcn]    
Risk Factors [qnco]    
HEPATOCELLULAR CARCINOMA [neop]    
Additive [qlco]    
Independent [idcn]    
Modification [ftcn]    
HEPATITIS B E ANTIGEN [imft]    
HEPATOCELLULAR CARCINOMA [neop]    
